Overview

Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
To investigate the steady state pharmacokinetics of different formulation of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ).
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Amlodipine
Hydrochlorothiazide
Telmisartan